Y. Abbas, “Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis”, Al-Kindy Col. Med. J, vol. 20, no. 3, pp. 216–221, Dec. 2024, doi: 10.47723/2km3dk27.